Mark Israel named executive director of Israel Cancer Research Fund

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Mark Israel, a pediatric oncologist and translational scientist, was appointed national executive director of the Israel Cancer Research Fund, a nonprofit organization dedicated solely to funding cancer research in Israel.

Israel joins ICRF from the Geisel School of Medicine at Dartmouth College, where he is a professor in the Department of Pediatrics, Medicine, and Molecular and Systems Biology. From 2001 to 2016, Israel served as the director of Dartmouth’s Norris Cotton Cancer Center.

For the last 12 years, Israel has been a volunteer member of the ICRF’s scientific review panel and the chair of the panel that evaluates translational cancer research proposals.

“Cancer research has never been more exciting or promising—and that is particularly true in Israel,” Israel said in a statement. “Israeli science knows no bounds. ICRF provides a singular opportunity to help build more recognition and support for the world-class cancer research of Israeli scientists, and to arm and empower its finest practitioners with the resources necessary to change the world.”

Table of Contents

YOU MAY BE INTERESTED IN

A Senate hearing that the administration hoped would be a routine check-in on the president’s 2026 MAHA-driven healthcare agenda erupted into a political firestorm as senators jumped at their first opportunity to confront HHS Secretary Robert F. Kennedy Jr. over the chaos engulfing the Centers for Disease Control and Prevention.
In December 1971, President Richard Nixon signed the National Cancer Act and declared a “War on Cancer.” In the past 54 years, the U.S. has invested $180 billion nominally, or approximately $322 billion when adjusted for inflation, in cancer research. This investment has paid dividends with more than 100 anticancer drugs brought to market in half a century—virtually all traceable to National Cancer Institute funding. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login